Yaguo Technology Co., Ltd, an airway management and respiratory therapy device maker based in Beijing, has reportedly raised “tens of millions” of renminbi in a Series A+ financing round. The round was led by Weifang Zhongke Haichuang Equity Investment Partnership, with contributions from Beijing Jinke Huiyu Venture Capital Partnership. The proceeds will be used for product research and development (R&D), marketing promotion, and marketing system construction in China and beyond.
Company Profile and Technology Platforms
Founded in 2014, Yaguo Technology boasts its airway management and respiratory therapy airway technology platform and electrophysiological technology platform. These platforms enable the development of innovative devices in the field of critical illness and chronic respiratory disease, as well as an intelligent disease management system based on data and community. Yaguo’s commitment to innovation is evident in its ability to create advanced solutions for respiratory therapy and airway management.
Future Development Plans
The funding will support Yaguo Technology’s ongoing efforts to advance its product portfolio, enhance marketing initiatives, and expand its market presence both domestically and internationally. This strategic investment underscores the company’s dedication to improving patient outcomes through innovative respiratory therapy solutions.-Fineline Info & Tech
